Overview
Maulik Majmudar, MD, is co-founder and chief medical officer of Biofourmis, a Boston-based global technology company founded in 2015 that delivers AI-driven remote patient monitoring and virtual care-at-home programs. Biofourmis’s platform page quotes Majmudar on using technology to close gaps in access to care and affordability — asking whether technology can make healthcare more accessible, acceptable, and affordable.
Biofourmis combines wearable biosensors, FDA-cleared predictive algorithms, virtual clinical teams, and EHR integration to support acute care-at-home, post-discharge monitoring, and chronic disease management.
Role and company
As Co-Founder and CMO, Majmudar provides clinical leadership for a platform with 21 proprietary AI algorithms, 70+ remote dynamic care pathways, and FDA-cleared analytics that generate personalized baselines and detect clinical deviation per biofourmis.com/platform. David Koretz serves as chief executive officer per Biofourmis about materials.
Biofourmis reports 100,000 patients served and 4 million+ data points captured per post-acute care patient per day on its platform page — scale metrics hospital-at-home buyers evaluate against pilot vendors.
Background and career context
Biofourmis’s platform page identifies Majmudar as Co-founder and Chief Medical Officer without listing prior employers on the cited page. His quoted emphasis on access, affordability, and acceptability frames Biofourmis as a care delivery platform addressing health equity and cost — not merely a device analytics vendor.
Majmudar’s CMO role ensures clinical escalation pathways and care pathway design reflect bedside practice rather than engineering convenience alone.
Company-building or leadership context
Majmudar co-founded Biofourmis in 2015 in Boston. The platform connects medical-grade devices, a robust data lake, AI-driven FDA-cleared algorithm models, patient mobile apps, physician dashboards, and 24/7/365 health navigator support per official product disclosures. January 2025 AdventHealth selected Biofourmis for acute care-at-home and RPM expansion in Central Florida per company newsroom.
Majmudar remains CMO through health-system partnerships and the January 2025 ActiGraph acquisition of Biofourmis Connect life-sciences division — a corporate structure change that preserved Majmudar’s clinical platform role.
Public milestones
2015: Biofourmis founded in Boston; Majmudar co-founder and CMO. January 6, 2025: AdventHealth collaboration for hospital-at-home and RPM. January 7, 2025: ActiGraph acquired Biofourmis Connect per Biofourmis newsroom. Platform cites AI algorithms reducing notification burden by up to 80% per Biofourmis data on file footnote.
Majmudar is named co-founder and CMO on the platform page reviewed July 10, 2026.
Why their work matters
Biofourmis under Majmudar’s clinical leadership tests whether predictive RPM AI can support hospital-at-home economics — replacing bed days with home monitoring without missing deterioration signals. FDA-cleared personalized baseline algorithms differentiate Biofourmis from consumer wearable vendors lacking clinical validation pathways.
For healthcare AI readers, Majmudar represents physician-founder influence on care pathway design in regulated RPM — distinct from ambient documentation or imaging AI categories.
Sources and references
Primary sourcing: Biofourmis platform page and About page, reviewed July 10, 2026.
- Biofourmis — Platform (biofourmis.com)
- Biofourmis — About (biofourmis.com)
Majmudar quote and co-founder CMO title from platform page only.
Biofourmis platform page cites 21 proprietary AI algorithms, 70+ remote dynamic care pathways, and device-agnostic connectivity operating through cellular connection without requiring hospital Wi-Fi infrastructure. These product specifications underpin Majmudar’s clinical vision for RPM programs deployable in post-acute and home settings where connectivity and escalation pathways determine whether remote monitoring reduces readmissions.
Majmudar’s quoted framing on access, affordability, and acceptability positions Biofourmis for health-system buyers evaluating hospital-at-home economics against inpatient bed costs — a CFO-relevant narrative Majmudar delivers as physician co-founder rather than pure technology sales leadership.